QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin

BACKGROUND: There is no known effective therapy for patients with coronavirus disease 2019 (COVID-19). Initial reports suggesting the potential benefit of hydroxychloroquine/azithromycin (HY/AZ) have resulted in massive adoption of this combination worldwide. However, while the true efficacy of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chorin, Ehud, Wadhwani, Lalit, Magnani, Silvia, Dai, Matthew, Shulman, Eric, Nadeau-Routhier, Charles, Knotts, Robert, Bar-Cohen, Roi, Kogan, Edward, Barbhaiya, Chirag, Aizer, Anthony, Holmes, Douglas, Bernstein, Scott, Spinelli, Michael, Park, David S., Stefano, Carugo, Chinitz, Larry A., Jankelson, Lior
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Heart Rhythm Society. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214283/
https://www.ncbi.nlm.nih.gov/pubmed/32407884
http://dx.doi.org/10.1016/j.hrthm.2020.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214283/
https://www.ncbi.nlm.nih.gov/pubmed/32407884
http://dx.doi.org/10.1016/j.hrthm.2020.05.014

Ejemplares similares